PL2204374T3 - Fosfoniany nukleozydów i ich analogi do leczenia zakażeń HPV - Google Patents

Fosfoniany nukleozydów i ich analogi do leczenia zakażeń HPV

Info

Publication number: PL2204374T3
Authority: PL; Poland
Prior art keywords: hpv; analogs; infections; treatment; nucleoside phosphonates
Prior art date: 2003-12-30

Application number

PL10158740T

Other languages

English (en)

Inventor

Xiaqin Cheng

Gary P Cook

Manoj C Desai

Edward Doerffler

Gong-Xin He

Choung U Kim

William A Lee

John C Rohloff

Jianying Wang

Zheng-Yu Yang

Original Assignee

Gilead Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-30

Filing date

2004-12-29

Publication date

2012-11-30

2004-12-29 Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc

2012-11-30 Publication of PL2204374T3 publication Critical patent/PL2204374T3/pl

Links

-1 Nucleoside phosphonates Chemical class 0.000 title 1
208000009608 Papillomavirus Infections Diseases 0.000 title 1
239000002777 nucleoside Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/44—Amides thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/664—Amides of phosphorus acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL10158740T 2003-12-30 2004-12-29 Fosfoniany nukleozydów i ich analogi do leczenia zakażeń HPV PL2204374T3 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US53374503P	2003-12-30	2003-12-30
US59098704P	2004-07-26	2004-07-26
US60659504P	2004-09-01	2004-09-01
EP04815956A EP1716162B1 (en)	2003-12-30	2004-12-29	Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
EP10158740A EP2204374B1 (en)	2003-12-30	2004-12-29	Nucleoside phosphonates and analogs thereof for the treatment of HPV-infections

Publications (1)

Publication Number	Publication Date
PL2204374T3 true PL2204374T3 (pl)	2012-11-30

Family

ID=34753695

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
PL04815956T PL1716162T3 (pl)	2003-12-30	2004-12-29	Fosfoniany, manofosfonamidy i bisfosfonamidy do leczenia chorób wirusowych
PL10158740T PL2204374T3 (pl)	2003-12-30	2004-12-29	Fosfoniany nukleozydów i ich analogi do leczenia zakażeń HPV
PL380828A PL212403B1 (pl)	2003-12-30	2004-12-29	Pochodna fosfonianowa, kompozycja farmaceutyczna zawierajaca ten zwiazek oraz jego zastosowanie w leczeniu guzów

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL04815956T PL1716162T3 (pl)	2003-12-30	2004-12-29	Fosfoniany, manofosfonamidy i bisfosfonamidy do leczenia chorób wirusowych

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL380828A PL212403B1 (pl)	2003-12-30	2004-12-29	Pochodna fosfonianowa, kompozycja farmaceutyczna zawierajaca ten zwiazek oraz jego zastosowanie w leczeniu guzów

Country Status (27)

Country	Link
US (5)	US7553825B2 (pl)
EP (2)	EP1716162B1 (pl)
JP (2)	JP4949852B2 (pl)
KR (2)	KR20120080240A (pl)
CN (2)	CN101816664B (pl)
AP (1)	AP2212A (pl)
AT (1)	ATE478082T1 (pl)
AU (2)	AU2004312546B2 (pl)
BR (1)	BRPI0418251C1 (pl)
CA (1)	CA2550222C (pl)
CY (2)	CY1111050T1 (pl)
DE (1)	DE602004028763D1 (pl)
DK (2)	DK1716162T3 (pl)
EA (1)	EA011304B1 (pl)
ES (2)	ES2350983T3 (pl)
HR (3)	HRP20060254A2 (pl)
IL (1)	IL176407A (pl)
IS (1)	IS2994B (pl)
NO (2)	NO338001B1 (pl)
NZ (1)	NZ548771A (pl)
PL (3)	PL1716162T3 (pl)
PT (2)	PT2204374E (pl)
RS (2)	RS52433B (pl)
SG (1)	SG149075A1 (pl)
SI (2)	SI2204374T1 (pl)
WO (1)	WO2005066189A1 (pl)
ZA (1)	ZA200606049B (pl)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8512718B2 (en)	2000-07-03	2013-08-20	Foamix Ltd.	Pharmaceutical composition for topical application
IL164809A0 (en) *	2002-05-13	2005-12-18	Metabasis Therapeutics Inc	Novel phosphonic acid basdrugs of pmea and its analogues
AU2003235501A1 (en) *	2002-05-13	2003-11-11	Metabasis Therapeutics, Inc.	PMEA and PMPA cyclic producing synthesis
US20060140984A1 (en)	2002-10-25	2006-06-29	Foamix Ltd.	Cosmetic and pharmaceutical foam
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
US10117812B2 (en)	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en)	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en)	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US8486376B2 (en)	2002-10-25	2013-07-16	Foamix Ltd.	Moisturizing foam containing lanolin
US9211259B2 (en)	2002-11-29	2015-12-15	Foamix Pharmaceuticals Ltd.	Antibiotic kit and composition and uses thereof
US8900554B2 (en)	2002-10-25	2014-12-02	Foamix Pharmaceuticals Ltd.	Foamable composition and uses thereof
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US8119109B2 (en)	2002-10-25	2012-02-21	Foamix Ltd.	Foamable compositions, kits and methods for hyperhidrosis
US8119150B2 (en)	2002-10-25	2012-02-21	Foamix Ltd.	Non-flammable insecticide composition and uses thereof
US7820145B2 (en)	2003-08-04	2010-10-26	Foamix Ltd.	Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7575739B2 (en)	2003-04-28	2009-08-18	Foamix Ltd.	Foamable iodine composition
US8795693B2 (en)	2003-08-04	2014-08-05	Foamix Ltd.	Compositions with modulating agents
US8486374B2 (en)	2003-08-04	2013-07-16	Foamix Ltd.	Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US7553825B2 (en)	2003-12-30	2009-06-30	Gilead Sciences, Inc.	Anti-proliferative compounds, compositions, and methods of use thereof
MXPA06014013A (es) *	2004-06-08	2007-03-15	Metabasis Therapeutics Inc	Sintesis mediada por acidos de lewis de esteres ciclicos.
WO2007002912A2 (en) *	2005-06-29	2007-01-04	Gilead Sciences, Inc.	Anti-proliferative compounds, compositions, and methods of use thereof
WO2007002808A1 (en) *	2005-06-29	2007-01-04	Gilead Sciences, Inc.	Anti-nonmelanoma carcinoma compounds, compositions, and methods of use thereof
ATE534377T1 (de) *	2006-05-16	2011-12-15	Gilead Sciences Inc	Verfahren und zusammensetzungen zur behandlung von hämatologischen erkrankungen
WO2007137196A2 (en) *	2006-05-19	2007-11-29	Threshold Pharmaceuticals, Inc.	Tubulin binding anti cancer compounds and prodrugs thereof
US8338593B2 (en) *	2006-07-07	2012-12-25	Gilead Sciences, Inc.	Modulators of toll-like receptor 7
US9023863B2 (en) *	2006-07-14	2015-05-05	Stiefel Research Australia Pty Ltd	Fatty acid pharmaceutical foam
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en)	2007-11-30	2009-06-04	Foamix Ltd.	Foam containing benzoyl peroxide
WO2010041141A2 (en)	2008-10-07	2010-04-15	Foamix Ltd.	Oil-based foamable carriers and formulations
WO2009072007A2 (en)	2007-12-07	2009-06-11	Foamix Ltd.	Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
AU2009205314A1 (en)	2008-01-14	2009-07-23	Foamix Ltd.	Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
TWI444384B (zh) *	2008-02-20	2014-07-11	Gilead Sciences Inc	核苷酸類似物及其在治療惡性腫瘤上的用途
US20120087872A1 (en)	2009-04-28	2012-04-12	Foamix Ltd.	Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013009A2 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en)	2009-10-02	2015-06-18	Journey Medical Corporation	Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
US12661407B2 (en)	2010-04-08	2026-06-23	Journey Medical Corporation	Compositions, gels and foams with rheology modulators and uses thereof
CN102309984B (zh) *	2011-07-22	2013-05-01	华东师范大学	一种磷酸酰胺类双功能催化剂及其合成方法
CA2857490C (en)	2011-12-22	2020-03-31	Geron Corporation	Guanine analogs as telomerase substrates and telomere length affectors
CN107312039B (zh)	2012-08-30	2019-06-25	江苏豪森药业集团有限公司	一种替诺福韦前药的制备方法
KR20150130355A (ko)	2013-03-15	2015-11-23	더 리전트 오브 더 유니버시티 오브 캘리포니아	비환식 뉴클레오사이드 포스포네이트 디에스테르
CN104804042B (zh) *	2014-01-24	2018-01-19	齐鲁制药有限公司	核苷酸膦酸酯类化合物、其药物组合物、制备方法及用途
EP3623364A1 (en)	2014-02-13	2020-03-18	Ligand Pharmaceuticals, Inc.	Prodrug compounds and their uses
CN105518011B (zh) *	2014-04-21	2018-07-27	四川海思科制药有限公司	氨基磷酸酯类衍生物制备方法及其中间体和中间体的制备方法
CN106687118A (zh)	2014-07-02	2017-05-17	配体药物公司	前药化合物及其用途
MX377983B (es)	2014-09-15	2025-03-04	Univ California	Análogos de nucleótidos.
WO2016106050A1 (en)	2014-12-26	2016-06-30	Emory University	N4-hydroxycytidine and derivatives and anti-viral uses related thereto
US10087209B2 (en) *	2015-04-28	2018-10-02	Ku Leuven Research & Development	Antiviral compounds, a process for their preparation, and their use for treating viral infections
WO2017007701A1 (en) *	2015-07-07	2017-01-12	Merck Sharp & Dohme Corp.	Antiviral phosphodiamide compounds
TWI620754B (zh) *	2015-08-26	2018-04-11		Method for preparing amino phosphate derivative and preparation method thereof
EP3875462A1 (en)	2015-09-15	2021-09-08	The Regents of The University of California	Nucleotide analogs
WO2017100108A1 (en)	2015-12-10	2017-06-15	Merck Sharp & Dohme Corp.	Antiviral phosphodiamide prodrugs of tenofovir
US10450335B2 (en)	2015-12-15	2019-10-22	Merck Sharp & Dohme Corp.	Antiviral oxime phosphoramide compounds
CN107849075A (zh) *	2016-01-19	2018-03-27	四川海思科制药有限公司	一种核苷类似物的磷酰胺酯前药及其应用
MX2020012139A (es)	2016-09-08	2021-01-29	Vyne Pharmaceuticals Inc	Composiciones y metodos para tratar rosacea y acne.
EP3515923A1 (en) *	2016-09-23	2019-07-31	Katholieke Universiteit Leuven	Prodrugs of fluorinated acyclic nucleoside phosphonates
WO2018080903A1 (en)	2016-10-26	2018-05-03	Merck Sharp & Dohme Corp.	Antiviral aryl-amide phosphodiamide compounds
KR20190100250A (ko)	2016-12-22	2019-08-28	머크 샤프 앤드 돔 코포레이션	테노포비르의 항바이러스 지방족 에스테르 전구약물
EP3558322B1 (en) *	2016-12-22	2021-09-29	Merck Sharp & Dohme Corp.	Antiviral benzyl-amine phosphodiamide compounds
CN108276444A (zh) *	2017-01-06	2018-07-13	米文君	一类新的化合物及其用途
RU2647576C1 (ru) *	2017-02-28	2018-03-16	Васильевич Иващенко Александр	Циклобутил (S)-2-[[[(R)-2-(6-аминопурин-9-ил)-1-метил-этокси]метил-фенокси-фосфорил]амино]-пропаноаты, способ их получения и применения
RU2020116571A (ru)	2017-12-07	2021-11-22	Эмори Юниверсити	N4-гидроксицитидин и производные и связанные с этим противовирусные применения
WO2019139919A1 (en)	2018-01-09	2019-07-18	Ligand Pharmaceuticals, Inc.	Acetal compounds and therapeutic uses thereof
AU2019207626B2 (en) *	2018-01-10	2023-10-05	Nucorion Pharmaceuticals, Inc.	Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
EP3823629B1 (en)	2018-07-19	2024-12-25	Merck Sharp & Dohme LLC	Phosphinic amide prodrugs of tenofovir
TWI846735B (zh) *	2018-09-28	2024-07-01	日商廣榮化學股份有限公司	醯胺鹽化合物之製造方法及醯胺鹽化合物
WO2021202669A2 (en)	2020-04-01	2021-10-07	Reyoung Corporation	Nucleoside and nucleotide conjugate compounds and uses thereof
LT4192474T (lt)	2020-08-07	2025-11-25		Fosfonamidų nukleotidų analogų provaistai ir jų farmacinis panaudojimas
KR20250052378A (ko)	2022-07-21	2025-04-18	안티바 바이오사이언시즈, 인크.	Hpv 감염 및 hpv-유도 신생물의 치료를 위한 조성물 및 투여 형태
CN118652277A (zh) *	2024-08-19	2024-09-17	成都工业学院	一种用于治疗癌症疾病的化合物的制备方法
CN118652276B (zh) *	2024-08-19	2024-10-15	成都工业学院	一种用于治疗癌症疾病的化合物的制备工艺
WO2026149934A1 (en) *	2025-01-10	2026-07-16	Tahrget Therapeutics Ltd.	Substituted adefovir compounds, compositions thereof, and methods of treatment therewith

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2528490C2 (de) *	1975-06-26	1983-04-28	Henkel KGaA, 4000 Düsseldorf	Verfahren zur Herstellung saurer Protease
US4816570A (en)	1982-11-30	1989-03-28	The Board Of Regents Of The University Of Texas System	Biologically reversible phosphate and phosphonate protective groups
US4968788A (en) *	1986-04-04	1990-11-06	Board Of Regents, The University Of Texas System	Biologically reversible phosphate and phosphonate protective gruops
ES2083580T3 (es)	1990-06-13	1996-04-16	Arnold Glazier	Profarmacos de fosforo.
DK0481214T3 (da) *	1990-09-14	1999-02-22	Acad Of Science Czech Republic	Prolægemidler af phosphonater
US5977061A (en) *	1995-04-21	1999-11-02	Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic	N6 - substituted nucleotide analagues and their use
US6312662B1 (en)	1998-03-06	2001-11-06	Metabasis Therapeutics, Inc.	Prodrugs phosphorus-containing compounds
US20030072814A1 (en) *	1999-12-16	2003-04-17	Maibach Howard I.	Topical pharmaceutical composition for the treatment of warts
US20030187261A1 (en) *	2000-01-07	2003-10-02	Libor Havlicek	Purine derivatives, process for their preparation and use thereof
HRP20030047B1 (hr) *	2000-07-21	2016-02-26	Gilead Sciences, Inc.	Prolijekovi koji su fosfonatni analozi nukleotida i metode njihovog odabira te njihova priprava
DE10236294A1 (de) *	2001-08-17	2003-02-27	Alstom Switzerland Ltd	Gasversorgungskontrolleinrichtung einer Gasspeicherkraftanlage
CN1168449C (zh) *	2002-12-23	2004-09-29	梁有国	抗人乳头瘤病毒感染的药物
US7553825B2 (en)	2003-12-30	2009-06-30	Gilead Sciences, Inc.	Anti-proliferative compounds, compositions, and methods of use thereof

2004
- 2004-12-29 US US11/026,303 patent/US7553825B2/en not_active Expired - Lifetime
- 2004-12-29 RS RS20120389A patent/RS52433B/sr unknown
- 2004-12-29 WO PCT/US2004/043969 patent/WO2005066189A1/en not_active Ceased
- 2004-12-29 JP JP2006547579A patent/JP4949852B2/ja not_active Expired - Lifetime
- 2004-12-29 DE DE602004028763T patent/DE602004028763D1/de not_active Expired - Lifetime
- 2004-12-29 HR HR20060254A patent/HRP20060254A2/xx not_active Application Discontinuation
- 2004-12-29 PL PL04815956T patent/PL1716162T3/pl unknown
- 2004-12-29 SI SI200431910T patent/SI2204374T1/sl unknown
- 2004-12-29 PL PL10158740T patent/PL2204374T3/pl unknown
- 2004-12-29 CN CN2010101456719A patent/CN101816664B/zh not_active Expired - Lifetime
- 2004-12-29 KR KR1020127013492A patent/KR20120080240A/ko not_active Ceased
- 2004-12-29 AP AP2006003675A patent/AP2212A/xx active
- 2004-12-29 EP EP04815956A patent/EP1716162B1/en not_active Expired - Lifetime
- 2004-12-29 PT PT10158740T patent/PT2204374E/pt unknown
- 2004-12-29 AT AT04815956T patent/ATE478082T1/de active
- 2004-12-29 KR KR1020067015535A patent/KR101214257B1/ko not_active Expired - Lifetime
- 2004-12-29 DK DK04815956.0T patent/DK1716162T3/da active
- 2004-12-29 BR BRPI0418251A patent/BRPI0418251C1/pt not_active IP Right Cessation
- 2004-12-29 DK DK10158740.0T patent/DK2204374T3/da active
- 2004-12-29 PT PT04815956T patent/PT1716162E/pt unknown
- 2004-12-29 HR HR20100626T patent/HRP20100626T1/hr unknown
- 2004-12-29 EP EP10158740A patent/EP2204374B1/en not_active Expired - Lifetime
- 2004-12-29 SI SI200431534T patent/SI1716162T1/sl unknown
- 2004-12-29 NZ NZ548771A patent/NZ548771A/en not_active IP Right Cessation
- 2004-12-29 EA EA200601263A patent/EA011304B1/ru not_active IP Right Cessation
- 2004-12-29 AU AU2004312546A patent/AU2004312546B2/en not_active Expired
- 2004-12-29 ES ES04815956T patent/ES2350983T3/es not_active Expired - Lifetime
- 2004-12-29 CA CA2550222A patent/CA2550222C/en not_active Expired - Lifetime
- 2004-12-29 PL PL380828A patent/PL212403B1/pl unknown
- 2004-12-29 CN CN2004800394690A patent/CN1950383B/zh not_active Expired - Lifetime
- 2004-12-29 RS RSP-2010/0490A patent/RS51476B/sr unknown
- 2004-12-29 SG SG200809660-4A patent/SG149075A1/en unknown
- 2004-12-29 ES ES10158740T patent/ES2389602T3/es not_active Expired - Lifetime
2005
- 2005-06-29 US US11/170,325 patent/US20060046981A1/en not_active Abandoned
- 2005-06-29 US US11/170,247 patent/US20060030545A1/en not_active Abandoned
2006
- 2006-06-19 IL IL176407A patent/IL176407A/en active IP Right Grant
- 2006-06-21 IS IS8516A patent/IS2994B/is unknown
- 2006-07-21 ZA ZA2006/06049A patent/ZA200606049B/en unknown
- 2006-07-28 NO NO20063479A patent/NO338001B1/no unknown
2009
- 2009-02-18 US US12/388,295 patent/US8088754B2/en not_active Expired - Lifetime
- 2009-05-05 US US12/436,004 patent/US8268802B2/en not_active Expired - Lifetime
2010
- 2010-11-17 CY CY20101101036T patent/CY1111050T1/el unknown
2011
- 2011-01-13 AU AU2011200141A patent/AU2011200141B2/en not_active Expired
- 2011-02-25 JP JP2011040828A patent/JP2011137029A/ja not_active Withdrawn
2012
- 2012-09-04 HR HRP20120699TT patent/HRP20120699T1/hr unknown
- 2012-09-10 CY CY20121100813T patent/CY1113103T1/el unknown
2015
- 2015-05-18 NO NO20150615A patent/NO338040B1/no unknown

Also Published As

Publication number	Publication date
HRP20100626T1 (hr)	2011-03-31
DK2204374T3 (da)	2012-09-10
RS52433B (sr)	2013-02-28
PL380828A1 (pl)	2007-03-19
SG149075A1 (en)	2009-01-29
AP2212A (en)	2011-03-01
US7553825B2 (en)	2009-06-30
ES2389602T3 (es)	2012-10-29
BRPI0418251A (pt)	2007-04-17
EP2204374B1 (en)	2012-06-13
DE602004028763D1 (de)	2010-09-30
NO20150615L (no)	2005-07-01
SI2204374T1 (sl)	2012-09-28
CA2550222A1 (en)	2005-07-21
EP2204374A1 (en)	2010-07-07
PT1716162E (pt)	2010-11-24
EA011304B1 (ru)	2009-02-27
ES2350983T3 (es)	2011-01-28
BRPI0418251B1 (pt)	2019-09-24
HK1146061A1 (en)	2011-05-13
PT2204374E (pt)	2012-09-17
US20060046981A1 (en)	2006-03-02
NO338040B1 (no)	2016-07-25
NO338001B1 (no)	2016-07-18
BRPI0418251C1 (pt)	2021-05-25
PL1716162T3 (pl)	2011-02-28
AU2004312546B2 (en)	2010-10-14
EP1716162B1 (en)	2010-08-18
SI1716162T1 (sl)	2010-12-31
RS51476B (sr)	2011-04-30
EP1716162A1 (en)	2006-11-02
JP4949852B2 (ja)	2012-06-13
AP2006003675A0 (en)	2006-08-31
US20060030545A1 (en)	2006-02-09
US20050222090A1 (en)	2005-10-06
NZ548771A (en)	2010-05-28
KR20120080240A (ko)	2012-07-16
HRP20060254A2 (en)	2006-10-31
KR101214257B1 (ko)	2012-12-21
HK1097276A1 (en)	2007-06-22
ZA200606049B (en)	2008-01-08
IL176407A0 (en)	2006-10-05
CA2550222C (en)	2013-05-28
CN1950383A (zh)	2007-04-18
JP2011137029A (ja)	2011-07-14
NO20063479L (no)	2006-10-02
AU2011200141A1 (en)	2011-02-03
CN1950383B (zh)	2010-06-09
US20090149400A1 (en)	2009-06-11
CN101816664A (zh)	2010-09-01
PL212403B1 (pl)	2012-09-28
CY1113103T1 (el)	2016-04-13
AU2004312546A1 (en)	2005-07-21
HRP20120699T1 (hr)	2012-09-30
DK1716162T3 (da)	2011-01-10
WO2005066189A1 (en)	2005-07-21
IS8516A (is)	2006-06-21
US8268802B2 (en)	2012-09-18
EA200601263A1 (ru)	2006-12-29
KR20060129360A (ko)	2006-12-15
US20090291922A1 (en)	2009-11-26
BRPI0418251B8 (pt)	2019-10-08
CY1111050T1 (el)	2015-06-11
CN101816664B (zh)	2012-04-18
IL176407A (en)	2012-12-31
IS2994B (is)	2018-03-15
ATE478082T1 (de)	2010-09-15
JP2007517065A (ja)	2007-06-28
AU2011200141B2 (en)	2012-02-16
US8088754B2 (en)	2012-01-03

Publication	Publication Date	Title
SI2204374T1 (sl)	2012-09-28	Nukleozidni fosfonati in njihovi analogi za zdravljenje HPV-infekcij
IL173909A0 (en)	2006-07-05	Use of modified cyclosporins for the treatment of hcv disorders
PT1610784T (pt)	2016-09-23	Formas de 5-azacitidina
SI1583542T1 (sl)	2008-12-31	Sestavki in postopki za kombinacijsko antivirusnoterapijo
DE60322451D1 (de)	2008-09-04	4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
EP1536834A4 (en)	2007-11-07	DESIGN OF CHEMOKINE ANALOGS FOR THE TREATMENT OF HUMAN DISEASES
GB0329874D0 (en)	2004-01-28	Compounds useful for the treatment of diseases
EP1680145A4 (en)	2007-05-23	METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGICAL DISEASES
EP1809265A4 (en)	2009-06-17	Methods for the treatment of synucleinopathies
AU2003258145A8 (en)	2004-02-25	Substituted phenylindoles for the treatment of hiv
GB0320238D0 (en)	2003-10-01	Treatment of disease
GB0213869D0 (en)	2002-07-31	The treatment of pain
EP1554298A4 (en)	2007-09-26	PROCESS FOR PREPARING 9-BETA-ANOMERIC NUCLEOSIDE ANALOGUE
GB2388027B (en)	2006-01-18	Use of palatinose for the treatment of mental stress
PT1590046T (pt)	2019-02-01	Composição para o tratamento de hiv ou sida
GB0201025D0 (en)	2002-03-06	The treatment of degenerative diseases
GB2410744B (en)	2006-04-12	Kinase inhibitors for the treatment of disease
AU2003240174A8 (en)	2003-12-22	Compositions for the treatment of edematous-firbrosclerotic panniculopathy
IL162492A0 (en)	2005-11-20	Use of alkylphosphocholines for the preventative treatment of protozoandiseases
GB0221712D0 (en)	2002-10-30	Methods of treatment
GB0313630D0 (en)	2003-07-16	Compositions for the enhanced treatment of depression
IL172528A0 (en)	2006-04-10	Surface treatment of sars-infected lungs
GB0317128D0 (en)	2003-08-27	Use of antitumoral compounds
GB0325957D0 (en)	2003-12-10	The treatment of pain
GB0322014D0 (en)	2003-10-22	The treatment of pain